GEN Exclusives

More »

GEN News Highlights

Back to Item »

Cubist to Pay $190M Up Front for Adolor to Gain Opioid Receptor Antagonists

Adolor stockholders will receive $4.35 cash per share and one CPR worth up to $4.50 per share, dependent on approval of opioid-associated constipation candidate.

Forward this item to a colleague:


 
   

(Separate multiple addresses by commas)

   

(Separate multiple addresses by commas)

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Connectomics Advocacy

How might connectomics maintain lasting support?